4. Medtronic’s InterStim uses neuromodulation to treat overactive bladder syndromeMedtronic recently announced five-year results for its InterStim neuromodulation device that is designed to help treat overactive bladder syndrome.
InterStim stimulates the sacral nerve. In the study, 272 of 340 participants received the implant and the remaining participants had drug therapy.
The results showed that there was an 82% success rate overall and a more than 50% improvement in symptoms. Urinary incontinence participants had an average reduction of 2.0 leaks per day and UF participants had an average reduction of 5.4 voids per day. They also had significant quality of life measures.